The Ophthalmologist has named the John A. Moran Eye Center’s Kathleen B. Digre, Mary Elizabeth Hartnett, and Liliana Werner to its 2021 Power List of the Top 100 Women in...
The John A. Moran Eye Center’s latest Focus annual report is here, featuring a tribute to Alan S. Crandall, MD, who embodied Moran's vision to provide hope, understanding, and treatment.
Backed by a new five-year, $2 million National Eye Institute Research Project Grant, the lab of Frans Vinberg, PhD, at the John A. Moran Eye Center is seeking a deeper...
A map of retinal disease generated by the John A. Moran Eye Center's Marclab for Connectomics offers a deeper understanding of a host of neurodegenerative diseases.
A collaborative program designed to treat thyroid eye disease (TED) at the ÑÇÖÞ×ÔοÊÓƵ of Utah offers patients access to highly customized treatments—including a delicate endoscopic surgery at the Moran Eye...
The mission of the Moran Eye Center’s Uveitis Division consists of three parts: provide state-of-the-art care to patients; serve as leaders in the clinical education of uveitis locally, nationally, and...
Ocular inflammatory disease, including uveitis, scleritis, and orbital inflammatory disease, can be acute or chronic, infectious, non-infectious, or present as a masquerade syndrome. Therefore, its management is manifold, and a...
Cataract surgery in uveitis patients requires special consideration. Both intraocular inflammation and its first-line treatment (steroids) contribute to cataract progression, and cataracts are a main cause of decreased vision in...
Clinical updates from the John A. Moran Eye Center’s Uveitis Division, including a new CMV screening protocol, managing patient care amid the COVID-19 pandemic, ongoing clinical trials, and selected research...
In resource-poor countries such as Myanmar, which has the second-highest number of people living with HIV in Southeast Asia, the rates of cytomegalovirus (CMV) retinitis and associated vision-threatening complications remain...
The John A. Moran Eye Center’s Uveitis Division took shape in 2003. Albert T. Vitale, MD, Akbar Shakoor, MD, and Marissa B. Larochelle, MD, comprise the only uveitis division between...
An oxysterol that accumulates in the eye with age can transform choroidal endothelial cells; interfering with the process might help patients with treatment-resistant age-related macular degeneration.
One of ophthalmology’s most prestigious research societies and other prominent organizations are tapping John A. Moran Eye Center physician-scientist Mary Elizabeth Hartnett, MD, for leadership roles in 2021 as her...
The John A. Moran Eye Center’s Global Outreach Division has expanded its donor-funded local care for uninsured and under-insured Utahns to patients with diabetes and other sight-threatening retinal conditions.
Paul S. Bernstein, MD, PhD, is investigating how lipids known as VLC-PUFAs could be used to prevent eye disease thanks to a new way to synthesize them for research.
The John A. Moran Eye Center's Clinical Ophthalmology Resource for Education (CORE) website aims to close educational gaps near and far. The unique website provides open-access, peer-reviewed ophthalmic education for...
Research to Prevent Blindness (RPB) has selected the John A. Moran Eye Center at the ÑÇÖÞ×ÔοÊÓƵ of Utah to receive an unrestricted annual grant of $115,000 to support eye research...
